Seeking and destroying lung cancer. Succeeding where Theranos failed. Treating resistant breast cancers. These are the aims of three San Diego biotechs that recently received funding
Seeking and destroying lung cancer. Succeeding where Theranos failed. Treating resistant breast cancers. These are the aims of three San Diego biotechs that recently received funding